Authors:
Luboshitz, J
Lubetsky, A
Schliamser, L
Kotler, A
Tamarin, I
Inbal, A
Citation: J. Luboshitz et al., Pharmacokinetic studies with FVIII/von Willebrand factor concentrate can be a diagnostic tool to distinguish between subgroups of patients with acquired von Willebrand syndrome, THROMB HAEM, 85(5), 2001, pp. 806-809
Authors:
Kenet, G
Lubetsky, A
Gitel, S
Luboshitz, J
Varon, D
Martinowitz, U
Citation: G. Kenet et al., Treatment of bleeding episodes in patients with hemophilia and an inhibitor: comparison of two treatment protocols with recombinant activated factor VII, BL COAG FIB, 11, 2000, pp. S35-S38
Citation: D. Hirsch et al., Treatment of antithyroid drug-induced agranulocytosis by granulocyte colony-stimulating factor: A case of primum non nocere, THYROID, 9(10), 1999, pp. 1033-1035
Authors:
Aviram, A
Blickstein, D
Stark, P
Luboshitz, J
Bairey, O
Prokocimer, M
Shaklai, M
Citation: A. Aviram et al., Significance of BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocythemia patients, LEUK LYMPH, 33(1-2), 1999, pp. 77-82
Authors:
Luboshitz, J
Bairey, O
Blickstein, D
Vaknin, H
Okon, E
Lahav, J
Prokocimer, M
Citation: J. Luboshitz et al., Cutaneous necrosis as a terminal paraneoplastic thromboembolic event in a patient with non-Hodgkin's lymphoma, J INTERN M, 245(3), 1999, pp. 301-305